U.S. markets closed

AmeriCann, Inc. (ACAN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.8000-0.0016 (-0.20%)
At close: 3:49PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.8016
Open0.8011
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.8000 - 0.9232
52 Week Range0.3600 - 1.9900
Volume51,782
Avg. Volume13,336
Market Cap19.357M
Beta (5Y Monthly)0.68
PE Ratio (TTM)N/A
EPS (TTM)-0.0740
Earnings DateFeb 24, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AMERICANN INC
    BCO: Lowering target price to $70.00BRINK'S CO/THE has an Investment Rating of HOLD; a target price of $70.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • ACCESSWIRE

    AmeriCann Announces Nearly 300% Increase in Quarterly Revenue from Comparable Quarter in 2020

    The Company Provided an Operations Update About the Increased Sales Growth at its Flagship Massachusetts Cannabis CenterBOSTON, MA / ACCESSWIRE / July 6, 2021 / AmeriCann, Inc. (OTCQB:ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, provided financial and operational updates for its flagship project, the Massachusetts Cannabis Center.

  • ACCESSWIRE

    AmeriCann Reports Record Quarterly Revenue and Positive EBITDA

    Company Also Achieved All-time Record Monthly Revenue in April, 2021Increased Sales Growth Obtained from its Flagship Massachusetts Cannabis CenterBOSTON, MA / ACCESSWIRE / May 17, 2021 / AmeriCann, Inc. (OTCQB:ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, provided financial and operational updates for its flagship project, the Massachusetts Cannabis Center.

  • ACCESSWIRE

    AmeriCann Announces Record Breaking Quarterly Revenue

    The Company Provided an Operations Update About the Increased Sales Growth at its Flagship Massachusetts Cannabis CenterBOSTON, MA / ACCESSWIRE / April 7, 2021 / AmeriCann, Inc. (OTCQB:ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, provided financial and operational updates for its flagship project, the Massachusetts Cannabis Center.